Expression and role of interleukin-9 in Vogt-Koyanagi-Harada disease.

about

Expression and role of interleukin-9 in Vogt-Koyanagi-Harada disease.

Item

http://www.wikidata.org/entity/Q41170370

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Expression and role of interleukin-9 in Vogt-Koyanagi-Harada disease.

@en

type

Item

label

Expression and role of interleukin-9 in Vogt-Koyanagi-Harada disease.

@en

prefLabel

Expression and role of interleukin-9 in Vogt-Koyanagi-Harada disease.

@en

P1476

Expression and role of interleukin-9 in Vogt-Koyanagi-Harada disease.

@en

P2093

Mingxing Wu

http://www.w3.org/2001/XMLSchema#string

Qian Wang

http://www.w3.org/2001/XMLSchema#string

Shaoqiu Jiang

http://www.w3.org/2001/XMLSchema#string

Xiyuan Zhou

http://www.w3.org/2001/XMLSchema#string

Zhixi Peng

http://www.w3.org/2001/XMLSchema#string

P2860

IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells

Neuron-mediated generation of regulatory T cells from encephalitogenic T cells suppresses EAE.

Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes

TGF-beta induces IL-9 production from human Th17 cells.

IL-9 induces VEGF secretion from human mast cells and IL-9/IL-9 receptor genes are overexpressed in atopic dermatitis.

Neutralization of IL-9 ameliorates experimental autoimmune encephalomyelitis by decreasing the effector T cell population.

IFN-β inhibits the increased expression of IL-9 during experimental autoimmune uveoretinitis.

Involvement of IL-9 in Th17-associated inflammation and angiogenesis of psoriasis

TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1.

Decreased 1,25-Dihydroxyvitamin D3 level is involved in the pathogenesis of Vogt-Koyanagi-Harada (VKH) disease.

P304

538-547

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28761327

http://www.w3.org/2001/XMLSchema#string

P932

5534488

http://www.w3.org/2001/XMLSchema#string